SCHEMBL13428159

SCHEMBL13428159

c1cc(-c2cccc3ccccc23)cc(-c2c3ccc(N4c5ccccc5CCc5ccccc54)cc3c(-c3ccc4ccccc4c3)c3ccc(N4c5ccccc5CCc5ccccc54)cc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.39
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
PIM1 P11309 2/20 0.33
HDAC8 Q9BY41 2/20 0.32
HDAC4 P56524 1/20 0.32
HDAC2 Q92769 1/20 0.32
PRKDC P78527 1/20 0.32
AKT1 P31749 1/20 0.32
PDE6D O43924 1/20 0.32
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13009184 0.95 CYP1A2 (0.34) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13009374 0.95 MET (0.37) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13009035 0.94 POLB (0.34) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13426993 0.94 MET (0.39) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13008450 0.94 CYP1A2 (0.36) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13009022 0.92 PDE6D (0.33) CYP1A2CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL13428182 0.92 POLB (0.33) CYP1A2CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL13009377 0.92 PIM1 (0.35) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13428153 0.91 CYP1A2 (0.36) METCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL13009038 0.91 CYP1A2 (0.36) METCYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A MET 3253/4885CYP1A2 2199/4885CYP2C9 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.